Overview | Life Sciences Patents

American Conference Institute’s 22nd Advanced Summit on Life Sciences Patents will provide practical insights on how to maximize your patent term and develop strategies to enhance global protections for your patent portfolio.

2024 Conference Chairs

MJ Edwards

Senior Associate General Counsel
Patent Prosecution Team Lead
Gilead Sciences Inc.

Nicole Woods

Vice President, Assistant General Patent Counsel
Eli Lilly and Company

Mercedes Meyer

Partner
Banner Witcoff LLP

GOVERNMENT SPEAKERS FROM THE USPTO

Sharon A. Israel

Chief Policy Officer and Director for International Affairs
U.S. Patent and Trademark Office

Honorable Susan Mitchell

Lead Judge, Patent Trial and Appeal Board
U.S. Patent and Trademark Office

Honorable Jacqueline Bonilla

Deputy Chief Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

Honorable Grace Obermann

Administrative Patent Judge, Patent Trial & Appeal Board
U.S. Patent and Trademark Office

SPECIAL INTERVIEW WITH A JUDGE OF THE UNIFIED PATENT COURT

Honorable Edger Brinkman

Presiding Judge
Unified Patent Court, the Hague Local Division

2024 Event Highlights

Establishing sound and successful protocols to procure and enforce life sciences patents in the U.S. and internationally

Mastering the art of claim balance and disclosure, drawing on lessons from patents and cases in the year post-Amgen v Sanofi

Decoding In Re Cellect and optimizing patent adjustments and overcoming double patenting challenges

Deep dives into the best regulatory and IP strategies for protecting digital health therapies and inventions created with the assistance of AI and machine learning

Re-evaluating the “pros and cons” of opting-into the EU’s Unitary Patent system, including a discussion of the first preliminary injunction granted by the Unified Patent Court (UPC)

CLE ACCREDITATION

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation. Learn more